Ref ID: 18390
Author:
Suman Pakala, Jessica Hostetler, Suchitra Pakala, Vinita
Joardar, Paul Bowyer, David Denning, William C. Nierman, Natalie D. Fedorova. J. Craig
Author address:
Venter Institute, Rockville MD, USA. Email: natalief@jcvi.org
Full conference title:
Asperfest 8
Abstract:
Aspergillus fumigatus is the most common causative agent of invasive aspergillosis (IA), an invasive and deadly infection that affects mostly
immunocompromised individuals. To enhance genomic resources available the A. fumigatus community, this study aims to provide (i) 2 additional
reference genome sequences; (ii) RNA-Seq based genome annotation upgrades; and (iii) mutational profiling of drug resistant strains. Here we report
the successful completion of the pilot phase of the project. To estimate the feasibility of the NGS approach, we first calculated the Illumina sequencing
error rate at the 10X cut-off, which turns out to be extremely low (2.4E-06). Sequencing two more azole-susceptible isolates, A1163 and AF210,
demonstrated high genetic variability of the A. fumigatus nuclear genome. Our preliminary analysis identified 57,000 and 77,000 SNPs in A1163 and
AF210, respectively, relative to AF293. With a fewexceptions, SNPs were stronglyenriched in the arms of the chromosomes relative to the center. Further
analysis identified over 50 highly variable genes (over 15 SNPs per 1 Kb) including the FluG-like protein and general amidase GmdB, which may be
useful for MLST typing. Notably, the cyp51A gene, associated with azole resistance has 10 SNPs in AF210, some previously described as not related
to drug resistance. The funding for the project has been provided by NIAIAD/NIH.
Abstract Number: 70)
Conference Year: 2011
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a